Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Accelerating the Adoption of New and Emerging Therapies for DLBCL: A Community-Based Quality Improvement Initiative

Peter A. Riedell, Ellie Moses-Okwei, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen

Blood (2023) 142 (Supplement 1): 7264.

https://doi.org/10.1182/blood-2023-173686

Published: 2023

Journal Articles

Optimizing the Integration of Genetic Testing in AML Care in Community Practice: Insights from a Quality Improvement Initiative

Catherine Lai, Adam Bagg, Lindsay Gurska, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen

Blood (2023) 142 (Supplement 1): 7277.

https://doi.org/10.1182/blood-2023-172976

Published: 2023

Journal Articles

Advancing Collaboration across the Multiple Myeloma Treatment Journey from Oncology Clinic to CAR T-Cell Center: A Paired Center Transformative Quality Improvement Initiative

Sikander Ailawadhi, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen

Blood (2023) 142 (Supplement 1): 5074.

https://doi.org/10.1182/blood-2023-173042

Published: 2023

Journal Articles

Key Findings from a Transformative Quality Improvement Initiative on Advancing CAR T-Cell Treatment in Non-Hodgkin Lymphoma

Manali K. Kamdar, Ellie Moses-Okwei, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen

Blood (2023) 142 (Supplement 1): 3705.

https://doi.org/10.1182/blood-2023-173681

Published: 2023

Journal Articles

Advancing Care of Patients with Sickle Cell Disease through a Transformative Quality Improvement Initiative

Biree Andemariam, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen

Blood (2023) 142 (Supplement 1): 7224.

https://doi.org/10.1182/blood-2023-173457

Published: 2023

Journal Articles

Optimizing Management of AML: Insights from a Community-Based Quality Improvement Initiative

Joshua F. Zeidner, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen

Blood (2023) 142 (Supplement 1): 7278.

https://doi.org/10.1182/blood-2023-173038

Published: 2023

Journal Articles

Identifying and Overcoming Racial Disparities in Multiple Myeloma Care: Results from a Large-Scale Equity-Focused Quality Improvement Initiative

Joseph R. Mikhael, Sam D.R. Dooyema, Shelby Sullivan, Jeffrey D. Carter, Cherilyn Heggen

Blood (2022) 140 (Supplement 1): 5103–5104.

https://doi.org/10.1182/blood-2022-160190

Published: 2022

Journal Articles

Addressing Racial Disparities to Advance Quality Care for Adults with Acute Leukemia: A Health Equity-Focused Quality Improvement Program

Manali I. Patel, Joao L. Ascensao, Lindsay Gurska, Shelby Sullivan, Jeffrey D. Carter, Cherilyn Heggen

Blood (2022) 140 (Supplement 1): 5098–5099.

https://doi.org/10.1182/blood-2022-158555

Published: 2022

Journal Articles

Transforming Chronic Lymphocytic Leukemia Care with Real-World Patient and Provider Perspectives: Results from Two Collaborative Patient-Provider Quality Improvement Programs

Matthew S. Davids, Shelby Sullivan, Jeffrey D. Carter, Cherilyn Heggen

Blood (2022) 140 (Supplement 1): 5081–5082.

https://doi.org/10.1182/blood-2022-160057

Published: 2022

Journal Articles

Advancing CAR T-Cell Care in Relapsed/Refractory Multiple Myeloma: Insights from a Collaborative Quality Improvement Initiative

Sikander Ailawadhi, Shelby Sullivan, Jeffrey D. Carter, Cherilyn Heggen

Blood (2022) 140 (Supplement 1): 5064–5065.

https://doi.org/10.1182/blood-2022-166454

Published: 2022

Journal Articles

Uncovering Gaps in the Evaluation and Integration of New Evidence into the Treatment and Management of Myelodysplastic Syndromes: Results from a Nationwide Survey

Amy E. DeZern, Ruben Mesa, Lindsay Gurska, Shelby Sullivan, Jeffrey D Carter, Cherilyn Heggen

Blood (2022) 140 (Supplement 1): 13127–13128.

https://doi.org/10.1182/blood-2022-158565

Published: 2022

Journal Articles

Advancing Personalized Care for Patients with Myeloproliferative Neoplasms (MPNs): Findings from a Phase 2 Scale-up Quality Initiative across Two Large U.S. Oncology Systems

Srdan Verstovsek, Ruben A. Mesa, Shelby Sullivan, Jeffrey D Carter, Cherilyn Heggen

Blood (2021) 138 (Supplement 1): 1911.

https://doi.org/10.1182/blood-2021-148477

Published: 2021

NARROW

Accelerating the Adoption of New and Emerging Therapies for DLBCL: A Community-Based Quality Improvement Initiative

Optimizing the Integration of Genetic Testing in AML Care in Community Practice: Insights from a Quality Improvement Initiative

Advancing Collaboration across the Multiple Myeloma Treatment Journey from Oncology Clinic to CAR T-Cell Center: A Paired Center Transformative Quality Improvement Initiative

Key Findings from a Transformative Quality Improvement Initiative on Advancing CAR T-Cell Treatment in Non-Hodgkin Lymphoma

Advancing Care of Patients with Sickle Cell Disease through a Transformative Quality Improvement Initiative

Optimizing Management of AML: Insights from a Community-Based Quality Improvement Initiative

Identifying and Overcoming Racial Disparities in Multiple Myeloma Care: Results from a Large-Scale Equity-Focused Quality Improvement Initiative

Addressing Racial Disparities to Advance Quality Care for Adults with Acute Leukemia: A Health Equity-Focused Quality Improvement Program

Transforming Chronic Lymphocytic Leukemia Care with Real-World Patient and Provider Perspectives: Results from Two Collaborative Patient-Provider Quality Improvement Programs

Advancing CAR T-Cell Care in Relapsed/Refractory Multiple Myeloma: Insights from a Collaborative Quality Improvement Initiative

Uncovering Gaps in the Evaluation and Integration of New Evidence into the Treatment and Management of Myelodysplastic Syndromes: Results from a Nationwide Survey

Advancing Personalized Care for Patients with Myeloproliferative Neoplasms (MPNs): Findings from a Phase 2 Scale-up Quality Initiative across Two Large U.S. Oncology Systems

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only